BSEInsider Trading / SAST3h ago · 22 Jul 2026, 05:13 pm
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Clarus Capital I & Others
Bliss GVS Pharma Ltd · 506197
✦ AI SummaryRegulatory
Bliss GVS Pharma Ltd has received a disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from Clarus Capital I & Others.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern3/10
Regulatory Risk8/10
Balance Sheet Risk4/10
Liquidity Impact6/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Bliss GVS Pharma Ltd - 506197 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011